Adult Stem Cells
Adult Stem Cells

Adult Stem Cells


The Adult Stem Cell Research (ASCR) Network is an Internet-based project of The Cell Therapy Foundation designed to be a well-maintained and reliable source of information for the public regarding adult stem cell research, as well as to be a community of practice and collaboration among fellow researchers. ASCR publishes the latest scientific news in the adult stem cell arena, identifies the leading researchers in the field, and locates key clinical trials; as well as connects the global community of adult stem cell researchers with one another.

Getting Started...

Available Clinical Trials

Multiple additional trials are presently ongoing – please contact Cell Therapy Foundation for additional information or specific inquiries.



 
Calgary researchers make stem cell breakthrough Print E-mail

May 24, 2012

Using a $600 machine, researchers at the University of Calgary have made a breakthrough in stem cell generation that could revolutionize medical treatment in the future.

It is called bioreactor technology, a method of creating millions of stem cells more quickly than ever before, using stem cells from adults, not embryos.

Until now, using stem cells from adults had severe limitations. Researchers found they were more likely to cause cancer in experiments with rats.

They are now using the new technology to make stem cells that can produce a rat that's cancer-free.

Dr. Derrick Rancourt says the discovery has the potential to be a scientific game changer, because researchers can now produce many more stem cells in a much shorter time, with enormous implications.

Read more...
 
IntelliCell BioSciences Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair Research Print E-mail
NEW YORK, May 22, 2012 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (OTCQB: SVFC.PK) announced today that it has entered a sponsored research agreement with the Institute for Cell Engineering and Regenerative Medicine (ICERM) at the University of Florida. A portion of the collaborative work will be to explore the physiological characteristics of the adult autologous vascular cells that are also referred to as stromal vascular fraction cells which form the basis of the IntelliCell product. The company also intends to explore combination therapies with patent pending bio-engineered products under development. The Company believes that the IntelliCell product is an efficient cellular delivery platform for a variety of therapeutic applications and will look to partner with technology developers.

Said Jon Dobson, Ph.D., Professor of biomedical engineering and biomaterials at the University of Florida, "We are pleased to be working with IntelliCell. Their technology is innovative and appears to hold promise for future regenerative medicine applications. The use of adult autologous (your own) stem cells to repair and regenerate tissues are of great interest to personalized medicine researchers." Professor Dobson is a leading researcher in bionanotechnology and nanomedicine applications and apart from regenerative medicine, his work also spans across fields as diverse as gene therapy, stem cell therapy and tumor targeting. He is also the Director of the newly formed Institute for Cell Engineering and Regenerative Medicine at the University of Florida.

Read more...
 
Karolinska University Hospital and GE Healthcare collaborate to advance technologies for cell therapy Print E-mail
Pioneering three-year study will investigate technology and workflow needs in a clinical setting

Stockholm, Sweden and Chalfont St Giles, UK - 22 May 2012 - Karolinska University Hospital Sweden and GE Healthcare Life Sciences today announced a joint research collaboration to drive advances in technologies and workflows for use in the rapidly emerging field of cell therapy. The three year collaboration will combine Karolinska University Hospital's world-class clinical expertise in cell therapy with GE Healthcare's industry-leading capabilities in cell biology and in technologies for the manufacture of biotherapeutics.

Cell therapy, the use of cells to replace damaged tissue or to treat disease, shows great promise for the treatment of many life-threatening and life-limiting illnesses such as cancer, heart disease, Parkinson's and age-related macular degeneration. There is enormous interest in the potential health benefits of cell therapy, with more than 500 studies worldwide currently at the clinical experimental phase. Karolinska University Hospital is leading several pioneering cell therapy trials for the treatment of cancer as well as neurological and metabolic disorders. GE Healthcare Life Sciences has over 30 years' experience in developing technologies for the manufacture of biotherapeutics. The company also has a pioneering research program aimed at developing new technologies that will help enable the new era of cell therapy.

Read more...
 
Patient's Stem Cells Show Promise in Treating Female Urinary Incontinence Print E-mail
5/22/2012

Results presented at American Urological Association Meeting in Atlanta

Findings from a multi-center trial led by researchers at Beaumont Hospital in Royal Oak, Mich. may give urologists another minimally invasive treatment option for women with stress urinary incontinence. The study showed that treating a woman with her own muscle-derived stem cells was both safe and effective. Unlike surgical treatments, this procedure takes place in a physician's office.

According to the National Institutes of Health, millions of women experience urinary incontinence, a medical condition that causes involuntary loss of urine. There are several types of incontinence. This study focused on women with stress urinary incontinence, the most common type, affecting women of all ages. It causes leakage of urine when sneezing, coughing, lifting, laughing or physical exertion.

The study's principal investigator, Kenneth Peters, M.D., medical director, Women's Urology Center, Beaumont Health System; and professor and chairman of Urology, Oakland University William Beaumont School of Medicine presented the results at the American Urological Association's Annual Meeting on May 22 in Atlanta.

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 Next > End >>

Page 1 of 7
All information is © 2012 by the Cell Therapy Foundation
Adult Stem Cells
Adult Stem Cells

* Designates sites with available clinical trials.

Click Here to Update your Lab

ASCR Network RSS

feed-image ASCR Latest
adult stem cells